Unilateral inferior altitudinal visual field defect related to COVID-19

Sharma, Akanksha; Kudchadkar, Urvashi Sinai; Shirodkar, Rohit; Usgaonkar, Ugam; Naik, Aparna

doi:10.4103/ijo.ijo_3666_20

Cited by 21 publications

(18 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Optic neuritis, disk edema, vascular tortuosity, acute macular neuroretinopathy (AMN), vasculitis retinal occlusion (RVO), retinal artery occlusions, intraretinal hemorrhages, cotton wool spots, uveitis, and endogenous endophthalmitis have all been reported in COVID-19 patients. 53 – 58…”

Section: Adults’ Ocular Manifestationsmentioning

confidence: 99%

Ocular manifestations of COVID-19

Al-Namaeh¹

2022

Ophthalmol Eye Dis

View full text Add to dashboard Cite

COVID-19 is a disease caused by a SARS-CoV-2 viral infection, a disease that was first detected in December 2019 in Wuhan, Hubei Province, China. COVID-19, formerly known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease, was officially named COVID-19 by the World Health Organization (WHO) in February 2020. By 25 May 2021, there were 33,579,116 confirmed cases with 599,109 COVID-19 deaths worldwide. The purpose of this review article is to provide an update on what is currently known about COVID-19 ocular symptoms in adults, the elderly, and children in the literature. Finally, this article will review the eye protection precautions that should be implemented in our clinics. To assess the current literature, PubMed was searched from December 2019 to 25 May 2021. Randomized trials, observational studies, case series or case reports, letters of research, and letters to editors were selected for confirmed cases of COVID-19. According to current scientific literature since the outbreak in December 2019, 205 articles have been published. Conjunctivitis, conjunctival hyperemia, and chemosis have been reported in adults with COVID-19. There have been few studies on children and elderly patients, and further research in these age groups is needed. Finally, wearing eye protection when seeing patients on a daily basis during the pandemic is essential.

show abstract

Section: Adults’ Ocular Manifestationsmentioning

confidence: 99%

Ocular manifestations of COVID-19

Al-Namaeh¹

2022

Ophthalmol Eye Dis

View full text Add to dashboard Cite

show abstract

“…CWSs can occur in a broad spectrum of diseases, such as hypertension and other diseases; thus, baseline and serial monitoring is important for clinical interpretation and management [16]. The posterior segment manifestations reported in COVID-19 patients include CWSs (Figure 1 and 2), retinal hemorrhages, central serous retinopathy, papillophlebitis, optic neuritis, optic atrophy, panuveitis, multi-focal retinitis, necrotizing retinitis, central retinal artery/vein occlusion, and Purtschner-like retinopathy [17][18][19][20][21]42]. Bilateral CWSs localized to the posterior pole revealed retinal nerve fiber layer (RNFL) infarcts on multimodal imaging, which was consistent with a Purtschner-like retinopathy, in a 59-year male with COVID-19 [17].…”

Section: Discussionmentioning

confidence: 99%

Posterior segment manifestations and imaging features of COVID-19

Sanjay¹,

Agrawal²,

Jayadev³

et al. 2021

Med Hypothesis Discov Innov Ophthalmol

View full text Add to dashboard Cite

Background: To report the posterior segment (uvea and retinal) manifestations and imaging characteristics of eyes of patients with and after coronavirus disease 2019 (COVID-19).Methods: We searched the PubMed/MEDLINE database to identify relevant articles using the following search terms: COVID-19, SARS-CoV-2, retina, uvea, optic nerve, retinal findings, posterior segment manifestations, and endophthalmitis. Articles published from December 1, 2019, to May 30, 2021, and indexed in PubMed/MEDLINE were screened.Results: For the purpose of this review, we included clinical features of 26 case reports and 8 case series. The posterior segment manifestations reported included cotton wool spots, retinal hemorrhages, central serous retinopathy, papillophlebitis, optic neuritis, panuveitis, multifocal retinitis, necrotizing retinitis, central retinal artery/vein occlusion, and Purtschner like retinopathy. In this review, we have also included optical coherence tomography angiography (OCTA) features that have been described in COVID-19 patients with pneumonia.Conclusions: COVID-19 patients can experience uveo-retinal manifestations even after recovery. These patients, even if asymptomatic for eye symptoms, should undergo an eye evaluation to rule out posterior segment involvement. OCTA performed in these patients revealed microvascular changes in the superficial and deep retinal plexuses. Some of these patients may require anticoagulant or antiplatelet therapy.

show abstract

“…Moreover, optic neuritis has been reported in COVID-19 patients and may occur with or without affection of other cranial nerves [ 27 , 28 ].…”

Section: Discussionmentioning

confidence: 99%

Simultaneous Encephalitis and Neuroretinitis After COVID-19 in a Young Adult: A Case Report

Poursadeghfard

Dorche

Nemati³

et al. 2021

J Neurol Res

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) pandemic greatly impacted many aspects of life in the world. Both neurological and ophthalmologic presentations after COVID-19 have been reported. Herein, we present a case of both neuroretinitis and encephalitis after COVID-19 in a young adult. Both presentations are among the rare presentations of COVID-19. Similar manifestations were not reported previously. The 18-year-old previously healthy girl initially presented with low-grade fever, nausea, vomiting, body pain, and headache. The patient tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse transcriptase-polymerase chain reaction (PCR) by using a nasal swab. Two days after the onset of COVID-19 symptoms, she reported blurred vision in both eyes, progressing to only light perception in 3 days. Based on the ophthalmological evaluation, she was diagnosed with neuroretinitis. A few days later, she gradually became drowsy, so she was referred for neurological evaluation. Brain magnetic resonance imaging (MRI) showed bilateral medial temporal T2 and fluid-attenuated inversion recovery (FLAIR) hyper-signal lesions suggestive of encephalitis. A low-dose steroid was started to treat the neuroretinitis. After about 2 weeks, significant improvement in visual acuity and resolution of retinitis patches were observed. Our case is rare in respect of both neurological and ophthalmic involvement.

show abstract

Unilateral inferior altitudinal visual field defect related to COVID-19

Cited by 21 publications

References 8 publications

Ocular manifestations of COVID-19

Ocular manifestations of COVID-19

Posterior segment manifestations and imaging features of COVID-19

Simultaneous Encephalitis and Neuroretinitis After COVID-19 in a Young Adult: A Case Report

Contact Info

Product

Resources

About